Proteogenomic strategies to advance drug development and precision medicine
An Olink Proteomics sponsored Science/AAAS webinar , originally broadcast on September 6, 2017, featuring Professor Ulf Gyllensten (Uppsala University) and Dr. Anders Mälarstig (Pfizer, Stockholm). Click the link below to register and access the on-demand recording of these presentations.
Introduction to Olink’s Multiplex panels: an innovative tool for protein biomarker research
This recorded seminar provides an introduction to PEA technology and its applications. Olink’s panels provide a high-throughput multiplex immunoassay product which allows simultaneous detection of 92 protein biomarkers in 90 samples simultaneously using only 1 µL of sample without compromising assay performance.
Strong impact of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs
In this recorded webinar, Professor Ulf Gyllensten from Uppsala University presents a large-scale study where 92 protein biomarkers are analyzed in 1,005 healthy individuals from a unique population using an Olink panel focused on oncology. This study reveals that genetics and lifestyle factors are strong influencers of protein levels in the bloodstream and suggests the establishment of personalized cut off values. Personally normalized plasma protein profiles can open up new possibilities of assessing protein biomarkers for prediction, prognosis or targeting different diseases.